Julia Grandjean

Julia Grandjean is a Scientist at Neurocrine Biosciences, responsible for driving in vitro assay development and establishing disease-relevant cell-based model systems for early-stage drug discovery projects. Before Neurocrine Biosciences, Julia worked as a Scientist at Ferring Pharmaceuticals, Protego Biopharma, and Scripps Research, where Julia led various research efforts related to molecular and cellular pharmacology, target validation, and high-throughput phenotypic screening. Julia holds a PhD in Chemical Biology from Scripps Research and a Bachelor of Arts in Molecular & Cell Biology from the University of California, Berkeley.